Core Viewpoint - The market experienced a decrease in profit-making effects in September compared to August, with short-term capital speculation amplifying market volatility. Economic high-frequency data indicates strong supply and weak demand, constraining expectations for economic resilience. The market is primarily consolidating to digest previous valuations, guided by industrial catalysts and mid-term report performance [1] Group 1: Economic and Market Outlook - The "14th Five-Year Plan" is expected to be a key macro variable in October, with policies promoting a unified national market and addressing industry issues. There is a focus on the growth potential of service consumption and the profitability improvement of cyclical industries [2] - October marks the disclosure period for Q3 reports, which will provide strong indicators for industry prosperity. There is a divergence in market expectations regarding performance realization, which needs clarification from earnings guidance [3] Group 2: Key Factors to Monitor - The 20th Central Committee's Fourth Plenary Session will be held in late October, focusing on the "14th Five-Year Plan" recommendations. Recent industry guidelines aim to promote technological manufacturing as the core economic driver, emphasizing service consumption and market unification [3] - The U.S. economic environment remains stable, with ongoing negotiations in U.S.-China trade relations. Recent announcements of new tariffs by the U.S. necessitate close monitoring of further negotiations [3] - The Federal Reserve's upcoming meeting at the end of October may indicate a balance between long-term inflation expectations and interest rate adjustments, which could impact market conditions [4] Group 3: Investment Recommendations - Focus on sectors aligned with the "14th Five-Year Plan" and Q3 report insights, particularly in technology manufacturing, which is expected to see high growth due to policy support and technological advancements. Key areas include AI applications and advanced semiconductor processes [4] - The innovative pharmaceutical and non-ferrous metals sectors are anticipated to benefit from renewed liquidity and economic recovery, with a focus on overseas business development [5] - The consumer sector may face short-term performance pressures, but stock prices have largely reflected mid-term pessimism. The "14th Five-Year Plan" suggests a shift towards domestic demand, potentially leading to moderate growth by 2026 [6]
金鹰基金：“十五五”蓝图启新程 金秋十月布局正当时
Xin Lang Ji Jin·2025-10-09 06:05